期刊文献+

EphrinA1在原发性肝细胞癌中的表达及临床意义 被引量:1

Expression and clinical significance of EphrinA1 in primary hepatocellular carcinoma
原文传递
导出
摘要 目的探讨原发性肝细胞癌中 EphrinA1的 mRNA 和蛋白表达水平及其临床意义。方法应用逆转录聚合酶链反应(RT-PCR)及免疫组织化学方法检测 EphrinA1的 mRNA 及蛋白在40例肝癌及相应的癌旁肝组织和10例正常肝组织中的表达水平,并分析其与临床病理学特点之间的关系。结果 40例肝癌组织及相应的癌旁肝组织和10例正常肝组织中均有 EphrinA1 mRNA 的表达。RT-PCR 分析显示 EphrinA1 mRNA 在肝癌组织(0.5413±0.1527)中的表达显著高于癌旁肝组织(0.3895±0.0549,P<0.05)和正常肝组织(0.3770±0.1055,P<0.05),而在癌旁肝组织(0.3895±0.0549)和正常肝组织(0.3770±0.1055)中的表达差异无统计学意义(P>0.05)。从正常肝组织、癌旁肝组织到肝癌组织,EphrinA1蛋白的阳性表达率分别为20%(2/10)、35%(14/40)和62%(25/40),呈递增趋势(x^2=14.762,P<0.05)。EphrinA1蛋白的过表达与肝癌细胞的分化程度、门静脉癌栓的形成及淋巴结转移等临床病理因素有关(P<0.05)。结论 EphrinA1蛋白的过表达与肝癌细胞的分化程度、淋巴结转移和门静脉癌栓有密切联系,提示其可能在肝癌的恶性转化、侵袭和转移过程中发挥重要作用。 Objective To investigate the expression and clinical significance of EphrinA1 mRNA and protein expression level in hepatecellular carcinoma. Methods Reverse transcription polymerase chain reaction(RT-PCR) and immunohistechemistry technique were used to detect the expression of the EphrinA1 mRNA and protein of 40 cases of hepatocellular carcinoma and their corresponding paracancerons tissues and 10 cases of normal liver tissues. The relationships with its clinical pathology characters were analyzed. Results The mRNA of EphrinA1 was expressed in all of the 40 cases of hepatocellular carcinoma and their corresponding paracancerons tissues and 10 cases of normal liver tissues. Semiquantitative analysis showed that the mRNA expression level of EphrinA1 in bepatocellular carcinoma( 0. 5413 ± 0. 1527 ) was greater than that in corresponding paracancerons tissues ( 0. 3895 ± 0. 0549, P 〈 0. 05 ) and normal liver tissues (0. 3770 ±0. 1055 ,P 〈0. 05) ;but between corresponding paracancerons tissues (0. 3895 ±0. 0549) and normal liver tissues (0. 3770 ±0. 1055) ,the mRNA expression level had no significant difference (P 〉 0. 05). The positive rates of EphrinA1 protein were 20% ( 2/10 ) in normal tissues, 35% ( 14/40 ) in paracancerons tissues and 62% (25/40) in hepatocellular carcinoma tissues, respectively; the protein expression level of EphrinA1 was gradually rising (X^2 = 14. 762 ,P 〈0. 05 ). The overexpression of EphrinA1 protein was correlated with histological differentiation,tumor thrombi in portal vein and lymph node metastasis (P 〈 0. 05 ). Conclusions The overexpression of EphrinA1 protein is correlated with histological differentiation,the lymph node metastasis and tumor thromhi in portal vein. It indicates that EphrinA1 may play an important role in the malignancy transformation,invasion progression and metastasis of bepatocellular carcinoma.
出处 《中华外科杂志》 CAS CSCD 北大核心 2007年第7期499-502,共4页 Chinese Journal of Surgery
关键词 肝细胞 门静脉癌栓 EPHRINA1 肝细胞癌 Carcinoma,bepotocellular Portal vein tumor thrombi EphrinA1
  • 相关文献

参考文献11

  • 1Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48 900 necropsies. Cancer, 1954,7:462 -503.
  • 2杨秉辉.第四届全国肝癌学术会议概况及关于原发性肝癌诊断标准及分期问题的讨论[J].中华普通外科杂志,2000,15(4):238-239. 被引量:57
  • 3Fox BP,Kandpal BP. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application.Biochem Biophys Res Commun, 2004,318 : 882 -892.
  • 4Gale NW, Holland SJ, Valenzuela DM, et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron,1996,17:9-19.
  • 5Dodelet VC, Pasquale EB. Eph receptors and ephrin ligands:embryogenesis to tumorigenesis. Oncogene,2000,19:5614-5619.
  • 6Holzman LB, Marks RM, Dixit VM. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol Cell Biol, 1990,10:5830-5838.
  • 7Ogawa K,Pasqualini P,Lindberg RA,et al. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene ,2000,19:6043-6052.
  • 8Straume O,Akslen LA. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the anglogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. Am J Pathol,2002,160 : 1009-1019.
  • 9Iida H, Honda M, Kawai HF, et al. Ephrin-A1 expression contributes to the malignant characteristics of α-fetoprotein producing hepatocellular carcinoma. Gut,2005,54:843-851.
  • 10Wu D, Suo Zm Kristensen GB, et al. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma. Gynecol Oncol,2004,94:312-319.

二级参考文献32

  • 1陈规划,陆敏强,蔡常洁,杨扬,何晓顺,朱晓峰.肝癌肝移植术后个体化化疗疗效初步分析[J].中华外科杂志,2004,42(17):1040-1043. 被引量:18
  • 2Kienle P,Weitz J,Klaes R,et al.Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.Arch Surg,2000,135:213.
  • 3Hemming AW,Cattral MS,Reed AI,et al.Liver transplantation for hepatocellular carcinoma.Ann Surg,2001,233:652-659.
  • 4Salizzoni M,Romagnoli R,Lupo F,et al.Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation.Transplantation,2003,76:844-848.
  • 5Freise CE,Ferrell L,Liu T,et al.Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma.Transplantation,1999,67:510-513.
  • 6Schlitt HJ,Neipp M,Weimann A,et al.Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.J Clin Oncol,1999,17:324-331.
  • 7Castroagudin JF,Gonzalez-Quintela A,Martinez J,et al.Bilateral adrenal metastases from hepatocellular carcinoma after liver transplantation.Hepatogastroenterology,2002,49:249-251.
  • 8Roayaie S,Frischer JS,Emre SH,et al.Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters .Ann Surg,2002,235:533-539.
  • 9Jonas S,Bechstein WO,Steinmuller T,et al.Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.Hepatology,2001,33:1080-1086.
  • 10Yao FY,Bass NM,Nikolai B,et al.Liver transplantation for hepatocellular carcinoma:analysis of survival according to the intention-to-treat principle and dropout from the waiting list.Liver Transpl,2002,8:873-883.

共引文献76

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部